Balfaxar
Generic name: Prothrombin Complex Concentrate, Human-lans
Dosage form: lyophilized powder for solution, for intravenous use
Drug class:
Anticoagulant reversal agents
Usage of Balfaxar
Balfaxar is used to reverse the effect of blood-thinning medicines like Warfarin in adult patients who need urgent surgery or procedures to reduce the risk of bleeding. Balfaxar works to restore blood coagulation by increasing blood clotting factors that become low when taking warfarin tablets.
Balfaxar is a non-activated four factor prothrombin complex concentrate (4F-PCC). Balfaxar contains vitamin K-Dependent factors Factor II (prothrombin), Factor VII, Factor IX and Factor X, as well as antithrombotic Proteins C and S.
The generic name for Balfaxar is prothrombin complex concentrate, human-lans.
Warfarin and other vitamin K antagonists are prescribed to prevent blood clots in patients who have had a heart attack, heart valve surgery, stroke, deep vein thrombosis/pulmonary embolism, or for certain types of irregular heartbeat (atrial fibrillation). Patients on warfarin or vitamin K antagonists have an increased risk of bleeding if they need to have urgent surgery or invasive procedures. Balfaxar (prothrombin complex concentrate, human-lans) is able to quickly restore coagulation, to reduce the risk of bleeding.
Balfaxar side effects
Get emergency medical help if you have signs of an allergic Reaction to Balfaxar: hives, rash; nausea, vomiting, feeling light-headed; fast heartbeats; chest tightness, wheezing, difficulty breathing; swelling of your face, lips, tongue, or throat.
Balfaxar side effects may include:
Before taking Balfaxar
You should not take this medicine if you are
Pregnancy
It is not known whether this medicine can harm an unborn baby. Tell your doctor if you are pregnant or planning a pregnancy.
Breastfeeding
It is not known if this medicine passes into breast milk or what effect it may have on milk production or on the breastfeeding infant.
Relate drugs
- Andexxa
- Coagulation factor Xa
- Coagulation factor xa recombinant, inactivated-zhzo
- Balfaxar
- Idarucizumab
- Kcentra
- Praxbind
- Prothrombin complex
- Prothrombin complex human
- Prothrombin complex human-lans
How to use Balfaxar
Balfaxar dose is based on body weight and pre-treatment INR.
Usual Balfaxar Adult Dose for Reversal of Acquired Coagulation Factor Deficiency:
INR 2 to less than 4: 25 units of Factor IX/kg body weight given intravenously INR 4 to 6: 35 units of Factor IX/kg body weight given intravenously INR greater than 6: 50 units of Factor IX/kg body weight given intravenously Maximum dose: INR 2 to less than 4: 2500 units of Factor IX INR 4 to 6: 3500 units of Factor IX INR greater than 6: 5000 units of Factor IX
Duration of therapy:
Single dose. Repeat dosing is not supported by clinical data and is not recommended.
Comments:
Dosing is based on body weight up to but not exceeding 100 kg. For patients weighing more than 100 kg, the maximum dose should not be exceeded. The dose based on actual potency is stated on the vial, which will vary from 20-32 Factor IX units/mL after reconstitution.The actual potency for a 500 unit vial ranges from 400-640 units/vial. The actual potency for a 1000 unit vial ranges from 800-1280 units/vial.
Warnings
Both fatal and non-fatal arterial and venous thromboembolic complications have been reported with this medicine in clinical trials and post-marketing surveillance. Patients receiving this medicine should be monitored for signs and symptoms of thromboembolic events.
Restarting anticoagulation medicines should be carefully considered as soon as the risk of thromboembolic events outweighs the risk of acute bleeding.
This medicine may not be suitable for patients who have had thromboembolic events in the previous 3 months.
This medicine is made from human plasma; therefore, may carry the risk of transmitting infectious agents, e.g., viruses, the variant Creutzfeldt-Jakob disease (vCJD) agent, and theoretically, the Creutzfeldt-Jakob disease (CJD) agent.
What other drugs will affect Balfaxar
Other drugs may interact with the prothrombin complex, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions